The impact of switching to tenofovir alafenamide on lipid profile and renal function in chronic hepatitis B: a retrospective cohort study

Özlem Gül, Zeynep İdil Erzurum Çiçek, Samet Bila

Open source

DOI
10.1097/meg.0000000000003268
Published
2026-08-11
Container
European Journal of Gastroenterology & Hepatology
Publisher
Ovid Technologies (Wolters Kluwer Health)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1097/meg.0000000000003268,
  title = {The impact of switching to tenofovir alafenamide on lipid profile and renal function in chronic hepatitis B: a retrospective cohort study},
  author = {Özlem Gül and Zeynep İdil Erzurum Çiçek and Samet Bila},
  year = {2026},
  journal = {European Journal of Gastroenterology \& Hepatology},
  doi = {10.1097/meg.0000000000003268},
  url = {https://doi.org/10.1097/meg.0000000000003268}
}

RIS

TY  - JOUR
TI  - The impact of switching to tenofovir alafenamide on lipid profile and renal function in chronic hepatitis B: a retrospective cohort study
AU  - Özlem Gül
AU  - Zeynep İdil Erzurum Çiçek
AU  - Samet Bila
PY  - 2026
JO  - European Journal of Gastroenterology & Hepatology
DO  - 10.1097/meg.0000000000003268
UR  - https://doi.org/10.1097/meg.0000000000003268
ER  - 

APA

Gül, Ö., Çiçek, Z. İ. E., & Bila, S. (2026). The impact of switching to tenofovir alafenamide on lipid profile and renal function in chronic hepatitis B: a retrospective cohort study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000003268

Source records